NCT00708448 2025-02-13
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients
University of Utah
Phase 1 Completed
University of Utah
National Cancer Institute (NCI)
Ontario Clinical Oncology Group (OCOG)